secwatch.observer — SEC 8-K summary
======================================

Issuer:     KORU Medical Systems, Inc. (KRMD)
CIK:        0000704440
Form:       8-K
Filed at:   2022-03-02T23:59:59+00:00
Accession:  0001161697-22-000132
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KORU Medical Q4 revenue up 60% to $6.5M, but full-year net loss widens to $4.6M
-------------------------------------------------------------------------------

- Q4 net revenues $6.5M (+60% YoY); adjusted growth 27.6% excluding prior-year inventory stocking.
- Full-year net loss $4.6M ($0.10 per share) vs $1.2M loss in 2020; adjusted EBITDA ($1.8M) vs $3.7M.
- Ended 2021 with $25.3M cash; expects FY2022 revenue of $26-27M with gross margin exit run rate 60%.
- Expanded label indications with three 510(k) clearances; announced strategic plan targeting $60M revenue by 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/704440/000116169722000132/0001161697-22-000132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/704440/000116169722000132/form_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001161697-22-000132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer